Zephyrnet Logo

Tag: biomarker

Top News

Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report

Clinical development productivity rose in 2023, primarily due to an improvement in the composite success rate, a function of phases successfully completed in the...

Nanotechnology Now – Press Release: Detecting breast cancer through a spit test

Home > Press > Detecting breast cancer through a spit testAbstract:Scientists have developed a saliva test that screens for breast cancer, which is...

Hand-held biosensor detects breast cancer biomarkers from saliva

Breast cancer is on the rise, but new tools for early detection could save lives. In Journal of Vacuum Science & Technology B, by AIP...

Modular Rapid Prototyping for Point of Care Diagnostics

The past five years have seen mainstream adoption of molecular and lateral flow point-of-care diagnostics. To combat the challenges caused by the pandemic, thousands...

Spiden Announces Breakthrough in Non-Invasive Glucose Monitoring, Adds Key Executive Hires and Secures $15m in Additional Funding

PFAFFIKON, SWITZERLAND, Jan 6, 2024 - (ACN Newswire) - Spiden, a pioneer in non-invasive biomarker monitoring technology, is thrilled to announce a significant scientific...

We’re Inching Closer to Answers for Why We Age and How to Slow Down the Clock

Why do we age? And how can we slow down the clock?This year, we inched closer to answers. Longevity research continued decoding the core...

CHMP Q&A Document on Development and Assessment for Companion Diagnostic Products | CHMP

The article highlights the key points associated with the regulatory framework for specific categories of medicinal products. Table of content ...

Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors...

No dose limiting toxicities were reported in the first cohort of ultra-high concentration of nitric oxide administered at 25,000 parts per million (PPM) Phase 1...

RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company’s Medical Advisory Board | BioSpace

PETALUMA, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies Inc. (OTCQB: RTGN) (“RetinalGeniX” or the “Company”), today announced that Anatoly Dritschilo, M.D. has...

The Weekly Notable Startup Funding Report: 11/27/23

The Weekly Notable Startup Funding Report takes us on a trip across various ecosystems in the US, highlighting some of the notable funding activity...

KDx Diagnostics Inc. announces new distribution partnerships in Europe for the URO17® NON-INVASIVE Urine Test for Bladder Cancer | BioSpace

LOS GATOS, Calif., Nov. 9, 2023 /PRNewswire/ -- KDx Diagnostics, a pioneering medical device company known for its innovative noninvasive urine test for bladder...

Latest Intelligence

spot_img
spot_img